182 related articles for article (PubMed ID: 16245256)
1. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system.
Mallamaci F; Tripepi G; Zoccali C
J Nephrol; 2005; 18(4):464-8. PubMed ID: 16245256
[TBL] [Abstract][Full Text] [Related]
2. Leptin and bone metabolism.
Coen G
J Nephrol; 2004; 17(2):187-9. PubMed ID: 15293517
[TBL] [Abstract][Full Text] [Related]
3. Role of leptin in reverse epidemiology in chronic kidney disease.
Scholze A; Tepel M
Semin Dial; 2007; 20(6):534-8. PubMed ID: 17991200
[TBL] [Abstract][Full Text] [Related]
4. Role of fat mass and adipokines in chronic kidney disease.
Axelsson J; Stenvinkel P
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):25-31. PubMed ID: 18090666
[TBL] [Abstract][Full Text] [Related]
5. [Leptin--adipose tissue hormone and its role in cardiovascular diseases].
Racek-Król B
Pol Merkur Lekarski; 2006 Jun; 20(120):713-6. PubMed ID: 17007277
[TBL] [Abstract][Full Text] [Related]
6. Body composition and cardiovascular risk in hemodialysis patients.
Nishizawa Y; Shoji T; Ishimura E
J Ren Nutr; 2006 Jul; 16(3):241-4. PubMed ID: 16825028
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
8. Leptin signaling and obesity: cardiovascular consequences.
Yang R; Barouch LA
Circ Res; 2007 Sep; 101(6):545-59. PubMed ID: 17872473
[TBL] [Abstract][Full Text] [Related]
9. Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients.
Zoccali C; Postorino M; Marino C; Pizzini P; Cutrupi S; Tripepi G;
J Intern Med; 2011 Feb; 269(2):172-81. PubMed ID: 21138492
[TBL] [Abstract][Full Text] [Related]
10. Is leptin the link between fat and bone mass?
Isaia GC; D'Amelio P; Di Bella S; Tamone C
J Endocrinol Invest; 2005; 28(10 Suppl):61-5. PubMed ID: 16550725
[TBL] [Abstract][Full Text] [Related]
11. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
12. Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity.
Fam BC; Morris MJ; Hansen MJ; Kebede M; Andrikopoulos S; Proietto J; Thorburn AW
Diabetes Obes Metab; 2007 Nov; 9(6):840-52. PubMed ID: 17924866
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue as an endocrine organ.
Ahima RS
Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():242S-249S. PubMed ID: 17021375
[TBL] [Abstract][Full Text] [Related]
15. Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients.
Zoccali C; Tripepi G; Cambareri F; Catalano F; Finocchiaro P; Cutrupi S; Pizzini P; Testa A; Spoto B; Panuccio V; Enia G; Mallamaci F
J Ren Nutr; 2005 Jan; 15(1):125-30. PubMed ID: 15648021
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease.
Zoccali C; Mallamaci F; Tripepi G
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V67-72. PubMed ID: 15284363
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.
Panuccio V; Cutrupi S; Pizzini P; Mallamaci F; Tripepi G; Zoccali C
Am J Kidney Dis; 2007 Dec; 50(6):1001-8. PubMed ID: 18037100
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
[TBL] [Abstract][Full Text] [Related]
19. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
Tankó LB; Christiansen C
Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
[TBL] [Abstract][Full Text] [Related]
20. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
